HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Thomas M Cardillo Selected Research

IMMU-110

7/2005Anti-CD74 antibody-doxorubicin conjugate, IMMU-110, in a human multiple myeloma xenograft and in monkeys.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Thomas M Cardillo Research Topics

Disease

46Neoplasms (Cancer)
01/2021 - 01/2002
10Lymphoma (Lymphomas)
06/2013 - 10/2004
8Pancreatic Neoplasms (Pancreatic Cancer)
05/2015 - 01/2002
6Multiple Myeloma
01/2018 - 10/2004
5Non-Hodgkin Lymphoma (Lymphosarcoma)
06/2010 - 12/2004
4Carcinoma (Carcinomatosis)
06/2015 - 10/2009
3Triple Negative Breast Neoplasms
10/2020 - 03/2014
3Stomach Neoplasms (Stomach Cancer)
01/2016 - 10/2014
3Leukemia
04/2012 - 06/2010
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2018 - 06/2010
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2018 - 06/2010
2Breast Neoplasms (Breast Cancer)
01/2016 - 03/2014
2Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
04/2012 - 06/2010
2B-Cell Lymphoma (Lymphoma, B Cell)
10/2009 - 02/2008
1Prostatic Neoplasms (Prostate Cancer)
01/2021
1Hodgkin Disease (Hodgkin's Disease)
01/2018
1Body Weight (Weight, Body)
01/2018
1Melanoma (Melanoma, Malignant)
01/2018
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2018
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2018
1Diarrhea
09/2015
1Colorectal Neoplasms (Colorectal Cancer)
06/2015
1Bites and Stings (Sting)
03/2014
1Hepatocellular Carcinoma (Hepatoma)
06/2013
1Renal Cell Carcinoma (Grawitz Tumor)
04/2013
1Adenocarcinoma of Lung
01/2013
1Graft vs Host Disease (Graft-Versus-Host Disease)
01/2013
1Rhabdomyosarcoma
01/2012
1Hematologic Neoplasms (Hematological Malignancy)
01/2012
1Hairy Cell Leukemia
06/2010

Drug/Important Bio-Agent (IBA)

14Immunoconjugates (Immunoconjugate)IBA
01/2021 - 07/2005
12Irinotecan (Camptosar)FDA LinkGeneric
10/2020 - 11/2008
10Immunoglobulin G (IgG)IBA
01/2018 - 04/2004
9AntigensIBA
01/2021 - 12/2004
8Monoclonal AntibodiesIBA
01/2012 - 09/2003
7sacituzumab govitecanIBA
10/2020 - 05/2015
6Peptides (Polypeptides)IBA
10/2012 - 05/2004
5HLA-DR Antigens (HLA-DR)IBA
01/2018 - 07/2005
5milatuzumabIBA
06/2013 - 12/2004
5HaptensIBA
10/2012 - 10/2005
5Radioisotopes (Radionuclides)IBA
10/2012 - 10/2004
5veltuzumabIBA
04/2012 - 10/2008
4Pharmaceutical PreparationsIBA
01/2018 - 04/2004
4Rituximab (Mabthera)FDA Link
06/2010 - 05/2004
4GemcitabineFDA Link
11/2004 - 01/2002
3labetuzumab govitecanIBA
01/2021 - 06/2015
3Proteins (Proteins, Gene)FDA Link
01/2016 - 10/2004
3ProdrugsIBA
09/2015 - 11/2008
3Bispecific AntibodiesIBA
03/2014 - 06/2009
3Doxorubicin (Adriamycin)FDA LinkGeneric
06/2013 - 07/2005
3AntibodiesIBA
01/2012 - 02/2008
2IMMU-114IBA
01/2018 - 06/2010
2Messenger RNA (mRNA)IBA
01/2016 - 10/2004
2Topoisomerase I InhibitorsIBA
06/2015 - 11/2008
2labetuzumabIBA
06/2015 - 11/2008
2ranpirnase (Pannon)IBA
03/2014 - 08/2010
2Antiviral Agents (Antivirals)IBA
01/2013 - 10/2009
2Ribonucleases (Ribonuclease)IBA
08/2010 - 09/2007
2LipidsIBA
06/2009 - 11/2004
2Immunoglobulin Fab FragmentsIBA
05/2006 - 10/2005
2Carcinoembryonic AntigenIBA
11/2005 - 10/2005
1Transcription Factors (Transcription Factor)IBA
01/2021
1ChromatinIBA
01/2021
1C 39 (C39)IBA
10/2020
1Biomarkers (Surrogate Marker)IBA
10/2020
1DNA (Deoxyribonucleic Acid)IBA
10/2020
17-ethyl-10-hydroxycamptothecin beta-glucuronideIBA
01/2018
1Histocompatibility Antigens Class IIIBA
01/2018
1talazoparibIBA
01/2017
1olaparibIBA
01/2017
1Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2017
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
01/2016
1Bevacizumab (Avastin)FDA Link
06/2015
1CaspasesIBA
05/2015
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
05/2015
1InterferonsIBA
10/2014
1CytokinesIBA
10/2014
1Biological ProductsIBA
03/2014
1Single-Chain AntibodiesIBA
03/2014
1Insulin-Like Growth Factor I (IGF-1)IBA
04/2013
1MTOR InhibitorsIBA
04/2013
1Cetuximab (Erbitux)FDA Link
01/2013
1epratuzumabIBA
01/2012
1LigandsIBA
01/2012
1Cysteine (L-Cysteine)FDA Link
01/2012
1Sirolimus (Rapamycin)FDA Link
01/2012
1EpitopesIBA
01/2012
1Insulin-Like PeptidesIBA
01/2012
1Immunotoxins (Immunotoxin)IBA
08/2010
1Membrane Glycoproteins (Membrane Glycoprotein)IBA
08/2010
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
06/2010
1JNK Mitogen-Activated Protein KinasesIBA
06/2010
1Interferon alpha-2 (Roferon-A)FDA Link
10/2009

Therapy/Procedure

21Therapeutics
01/2021 - 04/2004
6Drug Therapy (Chemotherapy)
01/2021 - 09/2003
5Immunotherapy
10/2017 - 09/2007
4Radioimmunotherapy
06/2008 - 01/2002
2Radiotherapy
04/2013 - 09/2006
1Castration
01/2021
1Drug Substitution
06/2015